(Q34585326)

3 August 2017

1 reference

title

Review article: faecal markers in the assessment of activity in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

3 August 2017

0 references

0 references

inflammation

0 references

author name string

Poullis A

1

1 reference

3 August 2017

Foster R

2

1 reference

3 August 2017

Northfield TC

3

1 reference

3 August 2017

Mendall MA

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Alimentary Pharmacology & Therapeutics

3 August 2017

1 reference

3 August 2017

16

1 reference

3 August 2017

4

1 reference

3 August 2017

675-681

1 reference

Review article: quantitative leucocyte scanning in the assessment of inflammatory bowel disease activity and its response to therapy

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestiv

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Sulfasalazine vs. steroids in Crohn's disease: David vs. Goliath?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

111Indium autologous granulocytes in the detection of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

111Indium autologous leucocytes in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

A Comparison of Oral Prednisolone Given as Single or Multiple Daily Doses for Active Proctocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Increased proteolysis and leucine aminopeptidase activity in faeces of patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Serum and faecal lysozyme in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Faecal elastase reflects disease activity in active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01196.X

10.1046/J.1365-2036.2002.01196.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference